You are here

  • Home
  • Archive
  • Volume 18, Issue 5
  • Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects

Article metrics

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects

 

Online download statistics by month:

Online download statistics by month: March 2019 to October 2024

AbstractFullPdf
Mar 20191200
Apr 20193700
May 20191700
Jun 20192600
Jul 20192700
Aug 20197600
Sep 20191600
Oct 20194000
Nov 20193603
Dec 20192600
Jan 20204500
Feb 20203601
Mar 20201300
Apr 20202900
May 20203200
Jun 20204900
Jul 20203301
Aug 202011700
Sep 20202500
Oct 20206101
Nov 20201401
Dec 20201200
Jan 20211200
Feb 20212400
Mar 20212500
Apr 2021500
May 2021800
Jun 2021101
Oct 20211400
Nov 20211000
Dec 20211400
Jan 20224702
Feb 20222200
Mar 20224000
Apr 20225101
May 20225601
Jun 20224401
Jul 20227301
Aug 20225600
Sep 20225100
Oct 20224000
Nov 20226400
Dec 20223200
Jan 202310302
Feb 20238800
Mar 2023400
Apr 20232600
May 20231401
Jun 20231400
Jul 20232702
Aug 20232300
Sep 20231100
Oct 20231700
Nov 20232800
Dec 20234000
Jan 20243800
Feb 20241001
Mar 20246100
Apr 20243003
May 20242900
Jun 20242200
Jul 20244000
Aug 20244600
Sep 20242102
Oct 20241000
Total2170025